# Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

> **NCT04902833** · — · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Pyruvate Kinase Deficiency
- Pyruvate Kinase Deficiency Anemia
- Hereditary Hemolytic Anemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasm
- Clonal Myeloid Neoplasm
- Myeloproliferative Neoplasm
- Acute Myeloid Leukemia
- Clonal Cytopenia of Undetermined Significance
- Other Clonal Myeloid Neoplasm
- Unexplained Coombs-negative Non-immune Hemolytic Anemia

## Interventions

- **PROCEDURE:** Blood Draw

## Key facts

- **NCT ID:** NCT04902833
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04902833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04902833, "Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04902833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*